News - UF Innovate

Genascence Granted FDA Fast Track Designation for GNSC-001 in Patients With Osteoarthritis (OA) of the Knee

UF Startup Genascence Corporation announced the U.S. Food and Drug Administration (FDA) has granted Fast Track designation (FTD) for GNSC-001, a potential first-in-class gene therapy for the treatment of patients with osteoarthritis (OA) of the knee.

United Nations Ratifies UF-Created Framework To Protect People on Cash Apps

UF researcher Kevin Butler developed the framework, which spells out guidance for countries to prevent fraud and abuse on mobile cash apps.

With an NIH Pioneer Award, UF Researcher Targets Common Infection

UF researcher Ivana Parker is targeting one of the most common and dangerous infections in women, backed by a $2.7 million grant from the National Institutes of Health.

Solid Biosciences Shares Updates on Inspire Duchenne Clinical Trial of SGT-003

Solid Biosciences, a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases that acquired UF startup AavantiBio, shared updates on the INSPIRE DUCHENNE clinical trial for their next-generation AAV micro-dystrophin gene therapy candidate, SGT-003, for the treatment of Duchenne.

Space Florida Announces Launch of Florida University Space Consortium

Space Florida’s Board of Directors designated the Florida University Space Research Consortium, as the state’s official space research entity, which will facilitate the awarding of NASA research grants in partnership with Kennedy Space Center.

The Wertheim UF Scripps Institute, UF Medicinal Chemistry Target Incurable Diseases

University of Florida researchers with expertise in drug discovery and chemistry are advancing potential treatments for challenging diseases via a new collaborative initiative.

Encore: UF Space Biologist Conducts Novel Research During Suborbital Flight

UF Space Biologist Rob Ferl discussed his groundbreaking experiment on how space travel affects plant genes, conducted with NASA’s Flight Opportunities program aboard the Blue Origin New Shepard rocket.

Soilcea Modified Sweet Orange Receives Favorable Decision

UF Startup Soilcea’s modified sweet orange, which reportedly has resistance to HLB, has been determined by the U.S. Department of Agriculture Animal and Plant Health Inspection Service (USDA APHIS) to be neither a plant pest nor a plant that requires regulation under 7 CFR part 340.

UF Accelerates AI Research Discoveries With HiPerGator Computing

The University of Florida has selected 20 research projects in artificial intelligence for accelerated development using the university’s HiPerGator supercomputer.

NIH Grants High Reward for High-Risk Health Innovations

Two UF researchers received New Innovator Awards from the National Institutes of Health, securing funding for research that could revolutionize invasive surgical implants and enhance disease detection understanding.

UF News